Skip to main content

Sexual health testing

Herpes blood test (IgG): when it helps and when a swab is better

Herpes can be tested for with a swab from a sore or, in selected situations, with a blood test for antibodies. For most people with symptoms the swab is the preferred route. This page explains what the IgG blood test can and cannot show, when specialists use it, and why a positive result can be difficult to interpret.

Last checked: 2026-10-10

Key facts

At a glance.

  • Swab first

    The NHS says a clinic will take fluid from a blister or sore with a small cotton bud, and that this test cannot be done if you do not have visible blisters or sores.

  • Preferred method

    The 2024 BASHH guideline recommends nucleic acid amplification tests (NAATs, such as PCR) on a swab from the lesion as the preferred diagnostic method for genital herpes.

  • What IgG shows

    BASHH says the antibody tests in routine use detect IgG, whose presence indicates infection at some time in the past without establishing when it occurred.

  • IgM is rarely useful

    BASHH says IgM testing is not recommended as a marker of recent infection, because it is not type specific and can be triggered by reactivation.

  • Not for routine screening

    The BASHH guideline notes that diagnosing genital herpes in someone without symptoms has not been shown to change behaviour or stop spread, and it lists specific situations in which antibody testing is useful.

The short answer: swab if you have a sore, blood test in selected cases

If you have a blister or sore that might be genital herpes, the NHS describes a swab test: a doctor or nurse at a sexual health clinic uses a small cotton bud to collect fluid from a blister or sore for testing. The British Association for Sexual Health and HIV (BASHH) guideline from 2024 calls testing a swab by NAAT, such as PCR, the preferred diagnostic method, and says confirming and typing the infection by directly detecting the virus in the lesions is essential.

A herpes blood test looks for antibodies rather than the virus itself. It is useful in a limited number of situations, which are described below, but it is not the first-line way to confirm a new episode, and it is not recommended as a general screening test for people without symptoms.

Swab compared with blood test

The two tests answer different questions. A swab asks whether virus is present in a lesion right now and which type it is. A blood test asks whether your immune system has made antibodies to the virus at some time in the past.

How the two main herpes tests differ, based on the NHS and BASHH
FeatureSwab from a sore (PCR/NAAT)Blood test (type-specific IgG)
What it detectsThe virus itself, and its type (HSV-1 or HSV-2)Antibodies that show infection at some point in the past
Needs a visible soreYes, the NHS says it cannot be done without blisters or soresNo
Tells you when you were infectedNo, the NHS says the test cannot tell how long you have had herpesNo, BASHH says IgG does not establish when infection occurred
Tells you where the infection isYes, because it is taken from the siteNo, BASHH says antibody results do not indicate the site of infection
Preferred for diagnosisYes, BASHH calls NAAT the preferred methodNo, used in selected situations only

When an antibody test is useful

BASHH lists situations in which antibody testing is beneficial, and these are the circumstances in which a specialist is most likely to suggest it.

  • Recurrent genital symptoms where the swab PCR is negative. Type-specific antibody tests can help rule out genital herpes in someone who has symptoms that suggest it.

  • Counselling after a first episode that was confirmed by PCR, to help tell recent infection from established infection, particularly in pregnancy and especially if the first episode occurs in the third trimester, because the result can inform the mode of delivery.

  • Investigating partners without symptoms of a person with genital herpes, including couples planning pregnancy, to identify partners who are not infected with the same type and so can be counselled about reducing risk.

Limits and pitfalls of the IgG blood test

BASHH sets out several reasons for caution. Type-specific antibody tests can take time to become positive after infection, and people with proven infection can lose their antibodies; the guideline says up to 12% of patients will subsequently lose their IgG antibodies. A negative result soon after a possible exposure therefore does not exclude infection.

False positives are also a concern. BASHH says false positive results are more common with low antibody index values, typically within three times the cut-off, and that low-prevalence populations have a lower positive predictive value. It gives an example in which an assay with 95% sensitivity and specificity has a positive predictive value of 86% in a sexually transmitted infection clinic population but 50% in a general antenatal population. A low-level positive may be retested using a different assay, or a repeat sample taken after at least 3 weeks.

Antibody results also do not distinguish how HSV-1 was acquired. BASHH explains that HSV-2 IgG implies anogenital infection, since nearly all HSV-2 infections are acquired sexually, but HSV-1 IgG can reflect oral infection acquired in childhood, so a positive HSV-1 result does not mean genital herpes.

The guideline also points out that the US Centers for Disease Control and Prevention does not advise routine antibody screening of everyone attending sexual health clinics, because diagnosing genital herpes in someone without symptoms has not been shown to change their sexual behaviour or stop the virus spreading.

Getting the best from a swab

Because the swab needs a lesion, timing matters. The NHS advises going to a sexual health clinic as soon as possible if you have symptoms, and says you should go even if you have not had sex for a long time, as blisters can take months or years to appear. It also says the test cannot be done if you do not have visible blisters or sores.

The NHS adds that if you have had symptoms for more than 5 days before attending, you can still be tested to find out the cause, although antiviral treatment for a first episode is intended to be started within 5 days of symptoms appearing. Many sexual health clinics offer walk-in services and often get results more quickly than GP practices.

Making sense of a result

A positive swab confirms current herpes in that lesion and its type. A positive antibody result shows past exposure to that virus type; with a positive HSV-1 result in particular, the infection may be oral rather than genital, The NHS notes that genital herpes can be caught if a cold sore touches your genitals.

The NHS describes genital herpes as a long-term infection with no cure, in which symptoms clear up by themselves but can come back, and recurrent outbreaks are usually milder than the first. Treatment from a sexual health clinic can help. Whatever the result, a clinician can explain what it means for you in context, including relationships and pregnancy.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • Is a blood test or a swab better for diagnosing herpes?

    A swab from a sore is preferred. BASHH recommends NAAT testing (such as PCR) of a swab from the lesion as the preferred method, whereas antibody blood tests are used in selected situations.

  • Can I be tested for herpes if I have no sores?

    The NHS says the swab test cannot be done if you do not have visible blisters or sores. A blood test can be done without sores, but BASHH does not advise routine antibody screening of people without symptoms.

  • Does a positive herpes IgG mean I have genital herpes?

    Not necessarily. BASHH says IgG shows infection at some time in the past, and HSV-1 IgG does not distinguish oral infection acquired in childhood from sexual acquisition. HSV-2 IgG implies anogenital infection.

  • Can a herpes blood test be wrong?

    Yes. BASHH says false positives are more common with low antibody index values and in low-prevalence groups, and that tests can be negative soon after infection or lose antibodies later. Low positives are often retested.

  • How long after exposure does a herpes IgG test turn positive?

    BASHH says type-specific antibody tests can take time to become positive and recommends repeating a test on a new sample after at least 3 weeks if recent seroconversion is suspected. A clinician can advise on timing.

  • What is an IgM herpes test?

    IgM is an early antibody. BASHH says IgM testing is rarely useful and is not recommended as a marker of recent infection, because it is not type specific and can be triggered by reactivation.

  • Why might a doctor suggest a herpes blood test in pregnancy?

    BASHH says type-specific antibody results can help when a first episode occurs in the third trimester, as they inform the mode of delivery. The NHS says people with a first episode in pregnancy are offered medicine from around 32 weeks.

  • Can a partner be tested for herpes without symptoms?

    BASHH lists investigating partners without symptoms, including couples planning pregnancy, as a situation where type-specific serology can be useful, to identify partners who may be uninfected and counsel them.

  • Will a herpes test tell me who I got it from?

    No. The NHS says the swab test cannot tell you how long you have had herpes or who you got it from, and symptoms might not appear for weeks or even years after infection.

  • Where should I go for a herpes test in the UK?

    The NHS advises a sexual health clinic as soon as possible if you have symptoms. A GP can see you but will probably refer you to a clinic if they think you might have genital herpes.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-10, next review 2027-10-10.